SCHEMBL6427907

SCHEMBL6427907

O=C1N=C(NCC2CCCCC2)SC1CC(=O)N1CCc2ccccc2C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
MAPT P10636 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
HPGD P15428 2/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
POLB P06746 2/20 0.45
KDM4E B2RXH2 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
KEAP1 Q14145 1/20 0.45
KCNH2 Q12809 1/20 0.43
DPP8 Q6V1X1 4/20 0.43
DPP4 P27487 3/20 0.43
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TSHR P16473 1/20 0.40
PRMT5 O14744 2/20 0.40
WDR77 Q9BQA1 2/20 0.40
NAMPT P43490 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6386550 0.93 NAMPT (0.42) ALDH1A1MAPTTDP1HPGDMEN1
SCHEMBL6427188 0.86 ALDH1A1 (0.57) ALDH1A1MAPTTDP1MEN1KMT2A
SCHEMBL6426510 0.86 ALDH1A1 (0.57) ALDH1A1MAPTTDP1MEN1KMT2A
SCHEMBL6393517 0.85 ALDH1A1 (0.55) ALDH1A1MAPTTDP1MEN1KMT2A
SCHEMBL1605788 0.83 TSHR (0.46) ALDH1A1MAPTPOLBKDM4ENPSR1
SCHEMBL6428776 0.83 ALDH1A1 (0.49) ALDH1A1MAPTTDP1HPGDMEN1
SCHEMBL6504722 0.82 TAAR1 (0.46) ALDH1A1MAPTTDP1MEN1KMT2A
SCHEMBL6427385 0.82 TSHR (0.47) ALDH1A1HPGDMEN1KMT2AKDM4E
SCHEMBL6427044 0.82 TSHR (0.47) ALDH1A1HPGDMEN1KMT2AKDM4E
SCHEMBL6503596 0.82 TSHR (0.47) ALDH1A1HPGDMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050239853-A1 New compounds BIOVITRUM AB (SE) 2005-10-27 US claimed
US-20050239853-A1 New compounds BIOVITRUM AB (SE) 2005-10-27 US disclosed
WO-2005075471-A2 THIAZOL-COMPOUNDS AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS BIOVITRUM AB (SE) 2005-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239853-A1 New compounds HSD11B1, CYP11B1, HSD3B1 ALDH1A1 67/4885MAPT 3607/4885TDP1 804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.